CDC Website CDC Website

To Join the NPIN community or

Home » HIV, HCV and Related Comorbidities in Rural Communities Affected by Opioid Injection Drug Epidemics in the United States: Building Systems for Prevention, Treatment and Control (UG3/UH3)

HIV, HCV and Related Comorbidities in Rural Communities Affected by Opioid Injection Drug Epidemics in the United States: Building Systems for Prevention, Treatment and Control (UG3/UH3)

This FOA will support biphasic (i.e., two stage, multi-method) research projects that inform community response and promote comprehensive, integrated approaches to prevent HIV and hepatitis C virus (HCV) infection, along with associated comorbidities such as hepatitis B virus (HBV) infection and sexually transmitted diseases (STDs), among people who inject drugs (PWID) in rural US communities. Opioid injection and its consequences (e.g., HIV, HCV, HBV, STDs and overdose) are the primary foci here. These projects should yield evidence of the effectiveness of community response models and best practices in responding to opioid injection epidemics that can be implemented by public health systems in similar rural communities in the US.

Locations
National
Fund Location Notes
Eligible Organizations
Number of Awards Given
Varies

Minimum Amount: 

$0.00

Maximum Amount: 

$0.00

Average Amount: 

$0.00

Award Amount: 

$6,500,000.00
Award Amount Notes
NIDA and partner components and agencies intend to commit an estimated total of $6.5 Million in FY2017 to fund 8-10 UG3 awards. Future year amounts will depend on annual appropriations and successful completion of UG3 study benchmarks that permit continuation to the UH3 award. It is anticipated that 6-8 UH3 awards will be funded.
Notes
RFA-DA-17-023, U24 Resource-Related Research Projects--Cooperative Agreements
Letter of Intent Date
12/10/17
Application Due Date
1/10/17
Award Date
10/12/16
Open Ended Date
10/12/16
Project Start Date
10/12/16
Application Contact
Richard
Jenkins PhD
United States
(301) 443-1923
jenkinsri@mail.nih.gov
(301) 443-1923
Technical Contact
GrantsInfo
GrantsInfo@nih.gov
United States
(301) 710-0267
(301) 710-0267
Fund Duration
The maximum project period is 5 years: up to 2 years for the first phase (UG3) and up to 3 years for the second phase (UH3).
Subjects
Audiences
Application Process
It is critical that applicants follow the instructions in the Research Instructions for the SF424 (R&R) Application Guide, including Supplemental Grant Application Instructions except where instructed in this funding opportunity announcement to do otherwise. Conformance to the requirements in the Application Guide is required and strictly enforced. Applications that are out of compliance with these instructions may be delayed or not accepted for review.
Focus Area

Fund Number: 

RFA-DA-17-014

Fund ID: 

5212

Last Updated: 

10/12/16